secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001213900-24-025811
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Medical Technologies starts limited commercial launch of OneRF Ablation System
--------------------------------------------------------------------------------

- OneRF System is FDA 510(k)-cleared for creating RF lesions in nervous tissue for functional neurosurgery.
- CEO Dave Rosa expects shipping to begin this week with first cases scheduled in April 2024.
- First therapeutic device for NeuroOne; third FDA 510(k)-cleared device alongside Evo electrode lines.
- Company estimates the brain ablation market at least $100M worldwide with significant growth potential.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024025811/0001213900-24-025811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024025811/ea0202492-8k_neuro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-025811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer